Nemec Sarah bought BOLT
October 22, 2025 · Form 4 insider transaction
Nemec Sarah bought 23,000 shares of Bolt Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
23,000
Price
$0.00
Total value
N/A
InsiderNemec Sarah
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateOctober 22, 2025
Filing dateOctober 24, 2025
Shares owned after23,943
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares represent restricted stock units that were received as an award, for no consideration. Each restricted stock unit represents the right to receive, at settlement, one share of common stock.; The restricted stock units subject to the award will vest in full on September 15, 2026, assuming continued employment through such date.